Faro Health Selected to Join Microsoft for Startups to Accelerate the Digital Transformation of Clinical Trials

Exclusive Program Designed to Help Startups Quickly Scale

SAN DIEGO—January  26, 2023—Faro Health, a leading company using technology to improve protocol design and eliminate operational errors and inefficiencies in clinical trials, was inducted into Microsoft for Startups, a global program dedicated to accelerating the trajectory of high-potential startups to enable growth at scale. As a program member, Faro Health now has exclusive access to Microsoft technology, mentorship, and business support as the company advances its cloud platform helping teams collaboratively design clinical protocols that balance the scientific needs of complex clinical development with the key drivers of performance, feasibility, and patient centricity.

Launched in 2019 in the Microsoft environment, Faro Health’s proprietary cloud-based platform is already helping a variety of enterprise-scale pharmaceutical and biotech companies to collaboratively develop and author complex clinical studies efficiently while using digital data flow to automate downstream processes. Faro’s platform ensures teams can collaboratively make informed decisions about the impact of every study activity and its associated measurement. Intuitive real time Insights powered by real word dataassist teams to adopt modern decentralized approaches. With visualizations of the patient journey always available, teams can focus on developing protocols that are more inclusive and patient centric.

Faro Health will use Microsoft technologies to reach a wide-scale audience in a short time. With built-in redundancy and security, as well as being guided by Azure’s Well-Architected Framework, Faro Health will also benefit from greater access to the powerful Microsoft Developer tools and exclusive wide-range programming support that help scale sales, marketing, business, and technological innovation faster and smarter.

“Faro Health is honored to be among such a select group of companies from around the world chosen to join the Microsoft for Startups program, and we plan to leverage this opportunity to its fullest,” said Scott Chetham, Co-Founder and CEO of Faro Health.  “Our participation in the program comes at a critical time for our company as we launch new offerings for customers. Finding partners like Microsoft has been a key success factor for us at Faro as we drive the digital transformation of clinical development.”

About Faro Health

Faro Health redefines how clinical protocols are developed by connecting all the stakeholders in the clinical trials ecosystem, including sponsor and CRO ClinOps teams, research sites, vendors, patients, and laboratories through a single software platform. The Faro platform provides a best-in-class standardized library of study activities that has been augmented with performance-related real world data to provide intuitive insights during protocol development. Faro brings balance, centricity and flexibility to protocol development through detailed analysis of the impact of each study activity, ensuring teams have the optimum protocol design for operationally complex trials. As a result, clinical protocols developed using Faro’s Smart Designer platform are operationally efficient in answering the right questions in the least burdensome way for patients, payers, and regulators. Sponsors, CROs, and researchers can learn more by visiting www.farohealth.com and requesting a consultation with a Faro solutions expert.

Media Contact
Kimberly Pospahala
Vice President of Commercial
Faro Health, Inc.
kimberly.pospahala@farohealth.com or sales@farohealth.com